Humulin N Articles
Pharma industry facing a lot of challenges, but there are opportunities, says Novo exec
10 November 2008
Generex says Oral-Lyn fits ADA/EASD guidance
10 November 2008
Novo Nordisk profit up 22% in 3rd qtr 2008
10 November 2008
Vit D expert recommends higher daily intake
3 November 2008
FDA clears Sanofi's Apidra for children
3 November 2008
Novo enters diabetes stem cell R&D alliance
3 November 2008
Lilly swings into loss in 3rd qtr on legal costs
3 November 2008
Pfizer's 3rd-qtr 2008 profit triples due to Exubera write-off; revenues flat at $12B
27 October 2008
Novartis to acquire Nektar unit for $115M
27 October 2008
Generex enrolls first metformin gum trial trialists
27 October 2008
Japan stock market week to Sept 29, 2008
6 October 2008
Takeda files alogliptinand Actos NDA in USA
29 September 2008
Neose sells assets to Novo, BioGeneriX
29 September 2008
Over 200 patients enrolled in Generex' Oral-Lyn trial
22 September 2008
Biocon reports on oral insulin trial
15 September 2008
NovoMix 30 leads to 2.4% HbA1c drop in insulin-naive patients.
15 September 2008
Lantus shows benefits over determir and NPH
15 September 2008
Byetta: better post-meal glucose reduction than Januvia
15 September 2008
Liraglutide improves multiple endpoints in LEAD-4
15 September 2008
Nutritionists note anti-aging effect of cherries
8 September 2008
CV Thera initiates CVT-3619 trial
8 September 2008
Emerging diabetes drugs; beta cell mass/function major target
8 September 2008
UPDATE: FDA considering strong warning on Byetta; potential fall-out for all GLP-1s
1 September 2008
ReceptorBio signs deal to develop Telik's IRAs
1 September 2008
BTG to receive $7M PH III trial milestone from Tolerx
1 September 2008
Novo Nordisk's 2nd-qtr 2008 profit falls 32%
18 August 2008
Generex receives approval to study Oral-lyn in IGT
18 August 2008
Sanofi-Aventis' second-quarter 2008 results disappoint analysts, hit by weak US dollar
11 August 2008
Novo Nordisk employee suspended after insider trading
4 August 2008
GPhA presses for US biogeneric pathway
4 August 2008
Merck & Co gains EU appro for Janumet
28 July 2008
UK guidance on insulin pumps updated
28 July 2008
EpiVax gets $600K grant from NIDDK
14 July 2008
ImClone completes Ph I trial enrollment
14 July 2008
ImClone starts Ph II IMC-A12 enrollment
14 July 2008
UPDATE: FDA panel votes in favor of outcomes over surrogate markers in diabetes drug approval
7 July 2008
LEEM says French drug market set to slow down
30 June 2008
Generex Oral-lyn non-inferior to insulin analogs
30 June 2008
EFPIA celebrates 30 years of achievements
30 June 2008
EMEA orders lung cancer warning for Pfizer's Exubera
23 June 2008
Novo Nordisk discontinues Ph III NovoSeven trial
16 June 2008
Liraglutide superior to Byetta: LEAD study
16 June 2008
Levemir comparable to glargine in control and DACON
16 June 2008
NovoMix 30 cuts HbA1c 2.6% in IMPROVE trial
16 June 2008
66% of Lantus patients meet ADA's 7% target
16 June 2008
Japan stock market week to June 9, 2008
16 June 2008
Roche study finds lack of diabetes education
9 June 2008
Alkermes' fiscal-2008 income soars on Reliant
9 June 2008
S Africa's expanding diabetes market
26 May 2008
Generex produces clinical samples of MetControl
19 May 2008
Sanofi-Aventis
5 May 2008
COMP recommends OD status for eight drugs
21 April 2008
Generex insulin spray enters US Ph III trial
21 April 2008
MannKind suspends insulin partnership talks
21 April 2008
Pfizer
14 April 2008
Hollis-Eden's 4th-qtr net loss narrows to $5.2M on payments for Triolex; files four US INDs in 2007
31 March 2008
French reimbursable spend "less dynamic"
24 March 2008
Drug industry in 2020, at Economist
17 March 2008
Generex' Oral-lyn packaged for trials
17 March 2008
Lilly pulls out of inhaled insulin development
17 March 2008
Affimed increases series B financing round to 30M euros
25 February 2008
Novo Nordisk names Pamela Harris as VP of diabetes sales
25 February 2008
India's Biocon buys 70% of AxiCorp GmbH
18 February 2008
Hollis-Eden's Triolex enters Ph I/II trial
18 February 2008
Nordisk signs French blood clot drug accord
18 February 2008
Nara Bio licenses MyoMouse
18 February 2008
Generex progresses Ph III Oral-lyn trial
14 February 2008
Novo Nordisk's 2007 EPS beats expectations
11 February 2008
Lilly's 4th qtr recovers from Zyprexa settlement
4 February 2008
Tercica begins dosing in Ph II IGF-1 deficiency trial
4 February 2008
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
